Skip to main content
Top
Published in: Clinical Rheumatology 4/2017

01-04-2017 | Original Article

Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population

Authors: Xiao-Ke Yang, Peng Li, Song Li, Chao Zhang, Bao-Zhu Li, Rui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye

Published in: Clinical Rheumatology | Issue 4/2017

Login to get access

Abstract

The aim of this study was to investigate the relationship between the single-nucleotide polymorphisms (SNPs) of interleukin 10 alpha receptor (IL10RA) gene and rheumatoid arthritis (RA) in a Chinese population. We examined 533 RA patients and 958 subjects as a control group. Three IL-10RA SNPs (rs9610, rs2229113 and rs3135932) were genotyped using TaqMan genotyping assays on Fluidigm 192.24 system. The IL-10RA rs9610 A allele was increased in patient group compared with control subjects (OR = 1.232, 95 % CI = 1.052–1.442, p = 0.030). Significant difference in genotype distribution was found in RA patients and controls (χ2 = 15.32, p < 0.001). We also discovered a statistical significance under the dominant model (GG + AG versus AA: OR = 0.676, 95 % CI = 0.546–0.837, p < 0.001). However, no significant difference was discovered in the recessive model (GG versus AG + AA: OR = 1.013, 95 % CI = 0.754–1.361, p = 0.932). Interestingly, significant differences were detected both in the allele and genotype frequencies of rs9610 between anti-CCP positive patients and anti-CCP negative patients (χ2 = 7.209, p = 0.007; χ2 = 9.061, p = 0.011; respectively). We also found a significant difference in genotype frequency at rs9610 in females compared with males (χ2 = 7.658, p = 0.022). Unfortunately, we failed to find any significant results between two IL-10RA SNPs (rs2229113 and rs3135932) and RA susceptibility. The findings suggest that IL-10RA rs9610 polymorphism might contribute to RA susceptibility.
Literature
1.
go back to reference McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2019CrossRefPubMed McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2019CrossRefPubMed
2.
go back to reference Silman AJ, and Hochberg MC (1993) Epidemiology of the rheumatic diseases. Oxford University Press, New York 504:31–71 Silman AJ, and Hochberg MC (1993) Epidemiology of the rheumatic diseases. Oxford University Press, New York 504:31–71
3.
go back to reference AJ M, Snieder H, AS R, Koskenvuo M, Kaprio J, Aho K, AJ S (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30–37CrossRef AJ M, Snieder H, AS R, Koskenvuo M, Kaprio J, Aho K, AJ S (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30–37CrossRef
4.
go back to reference de Vries R (2011) Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol 23(3):227–232CrossRefPubMed de Vries R (2011) Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol 23(3):227–232CrossRefPubMed
5.
go back to reference Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182CrossRefPubMed Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182CrossRefPubMed
6.
go back to reference Kremer JM et al (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl JMed 349(20):1907–1915CrossRef Kremer JM et al (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl JMed 349(20):1907–1915CrossRef
7.
go back to reference Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581CrossRefPubMed Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581CrossRefPubMed
8.
go back to reference Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ (2013) Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol 32(9):1255–1266CrossRefPubMed Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ (2013) Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol 32(9):1255–1266CrossRefPubMed
9.
go back to reference Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM et al (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647–1655CrossRefPubMed Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM et al (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647–1655CrossRefPubMed
10.
go back to reference Kirkham BW, MN L, JP E, KM J, PA B, CS L et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis. Arthritis Rheum 54:1122–1131CrossRefPubMed Kirkham BW, MN L, JP E, KM J, PA B, CS L et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis. Arthritis Rheum 54:1122–1131CrossRefPubMed
11.
go back to reference SP S, Thumboo J, Vasoo S, ST T, Tse C, KY F (2007) In vivo pro and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99 SP S, Thumboo J, Vasoo S, ST T, Tse C, KY F (2007) In vivo pro and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99
12.
go back to reference Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765CrossRefPubMed Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765CrossRefPubMed
13.
go back to reference Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143–1148PubMed Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143–1148PubMed
14.
go back to reference JD W, EL L, CA C, Weiss K, Kovesdi I, JC G et al (1999) Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625–3632 JD W, EL L, CA C, Weiss K, Kovesdi I, JC G et al (1999) Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625–3632
15.
go back to reference RP D, Dickensheets H, DS F (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interf Cytokine Res 19(6):563–573CrossRef RP D, Dickensheets H, DS F (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interf Cytokine Res 19(6):563–573CrossRef
16.
go back to reference Kotenko SV, Pestka S (2000) Jak-stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19(21):2557–2565CrossRefPubMed Kotenko SV, Pestka S (2000) Jak-stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19(21):2557–2565CrossRefPubMed
17.
go back to reference Logsdon NJ, Jones BC, Josephson K, Cook J, Walter MR (2002) Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interf Cytokine Res 22(11):1099–1112CrossRef Logsdon NJ, Jones BC, Josephson K, Cook J, Walter MR (2002) Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interf Cytokine Res 22(11):1099–1112CrossRef
18.
go back to reference Ding Y, Qin L, Zamarin D, Kotenko SV, Pestka S, Moore KW et al (2001) Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 167(12):6884–6892CrossRefPubMed Ding Y, Qin L, Zamarin D, Kotenko SV, Pestka S, Moore KW et al (2001) Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 167(12):6884–6892CrossRefPubMed
19.
go back to reference Arnett F, Edworthy C (1988) The American rheumatism association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett F, Edworthy C (1988) The American rheumatism association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
20.
go back to reference Taylor PC (2003) Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 9:1095–1106CrossRefPubMed Taylor PC (2003) Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 9:1095–1106CrossRefPubMed
21.
go back to reference Lubberts E, van den Berg WB (2001) Potential of modulatory cytokines in the rheumatoid arthritis process. Drug News Perspect 14:517–522CrossRefPubMed Lubberts E, van den Berg WB (2001) Potential of modulatory cytokines in the rheumatoid arthritis process. Drug News Perspect 14:517–522CrossRefPubMed
22.
go back to reference Wolk K, Witte E, Reineke U, Witte K, Friedrich M, Sterry W et al (2005) Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6(1):8–18PubMed Wolk K, Witte E, Reineke U, Witte K, Friedrich M, Sterry W et al (2005) Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6(1):8–18PubMed
23.
go back to reference Reineke U, Schneider-Mergener J, Glaser RW, Stigler RD, Seifert M, Volk HD et al (1999) Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 12(4):242–248CrossRefPubMed Reineke U, Schneider-Mergener J, Glaser RW, Stigler RD, Seifert M, Volk HD et al (1999) Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 12(4):242–248CrossRefPubMed
24.
go back to reference Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR (2006) Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem 281(46):35088–35096CrossRefPubMed Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR (2006) Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem 281(46):35088–35096CrossRefPubMed
25.
go back to reference Neidhart M, Jüngel A, Ospelt C, Michel BA, Gay RE, Gay S (2005) Deficient expression of interleukin-10 receptor alpha chain in rheumatoid arthritis synovium: limitation of animal models of inflammation. Arthritis Rheum 52(10):3315–3318CrossRefPubMed Neidhart M, Jüngel A, Ospelt C, Michel BA, Gay RE, Gay S (2005) Deficient expression of interleukin-10 receptor alpha chain in rheumatoid arthritis synovium: limitation of animal models of inflammation. Arthritis Rheum 52(10):3315–3318CrossRefPubMed
26.
go back to reference Hermann J, Gruber S, Neufeld JB, Grundtner P, Graninger M, Graninger WB et al (2009) IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 27(4):603–608PubMed Hermann J, Gruber S, Neufeld JB, Grundtner P, Graninger M, Graninger WB et al (2009) IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 27(4):603–608PubMed
27.
go back to reference Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR et al (2013) Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer 133(1):201–213CrossRefPubMed Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR et al (2013) Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer 133(1):201–213CrossRefPubMed
28.
go back to reference Bi X, Zheng T, Lan Q, Xu Z, Chen Y, Zhu G et al (2012) Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol 87(8):766–769CrossRefPubMedPubMedCentral Bi X, Zheng T, Lan Q, Xu Z, Chen Y, Zhu G et al (2012) Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol 87(8):766–769CrossRefPubMedPubMedCentral
Metadata
Title
Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population
Authors
Xiao-Ke Yang
Peng Li
Song Li
Chao Zhang
Bao-Zhu Li
Rui-Xue Leng
Hai-Feng Pan
Dong-Qing Ye
Publication date
01-04-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 4/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3449-9

Other articles of this Issue 4/2017

Clinical Rheumatology 4/2017 Go to the issue